Drugs / Lidocaine/Prilocaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07694271 Comparator | Feb 2025 → Jun 2026 overdue | chronic kidney disease | Taipei Medical University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lidocaine/Prilocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07694271 ↗ |
| Route | Topical | “Topical application of lidocaine/prilocaine gel to two puncture areas under an occlusive dressing for up to 1 hour before cannulation.” NCT07694271 ↗ |